Literature DB >> 1689998

Dephosphorylation of insulin-receptor autophosphorylation sites by particulate and soluble phosphotyrosyl-protein phosphatases.

M J King1, G J Sale.   

Abstract

Insulin stimulates autophosphorylation of the insulin receptor on multiple tyrosines in three domains: tyrosines 1316 and 1322 in the C-terminal tail, 1146, 1150 and 1151 in the tyrosine-1150 domain, and possibly 953, 960 or 972 in the juxtamembrane domain. In the present work the sequence of dephosphorylation of the various autophosphorylation sites by particulate and cytosolic preparations of phosphotyrosyl-protein phosphatase from rat liver was studied with autophosphorylated human placental insulin receptor as substrate. Both phosphatase preparations elicited a broadly similar pattern of dephosphorylation. The tyrosine-1150 domain in triphosphorylated form was found to be exquisitely sensitive to dephosphorylation, and was dephosphorylated 3-10-fold faster than the di- and monophosphorylated forms of the tyrosine-1150 domain or phosphorylation sites in other domains. The major route for dephosphorylation of the triphosphorylated tyrosine-1150 domain involved dephosphorylation of one of the phosphotyrosyl pair, 1150/1151, followed by phosphotyrosyl 1146 to generate a species monophosphorylated mainly (greater than 80%) at tyrosine 1150 or 1151. Insulin receptors monophosphorylated in the tyrosine-1150 domain disappeared slowly, and overall the other domains were completely dephosphorylated faster than the tyrosine-1150 domain. Dephosphorylation of the diphosphorylated C-terminal domain yielded insulin receptor in which the domain was singly phosphorylated at tyrosine 1322. Triphosphorylation of the insulin receptor in the tyrosine-1150 domain appears important in activating the receptor tyrosine kinase to phosphorylate other proteins. The extreme sensitivity of the triphosphorylated form of the tyrosine-1150 domain to dephosphorylation may thus be important in terminating or regulating insulin-receptor tyrosine kinase action and insulin signalling.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689998      PMCID: PMC1131122          DOI: 10.1042/bj2660251

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects.

Authors:  H Maegawa; D A McClain; G Freidenberg; J M Olefsky; M Napier; T Lipari; T J Dull; J Lee; A Ullrich
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

2.  Two systems in vitro that show insulin-stimulated serine kinase activity towards the insulin receptor.

Authors:  D M Smith; M J King; G J Sale
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

3.  Identification of insulin receptor tyrosine residues autophosphorylated in vitro.

Authors:  H E Tornqvist; M W Pierce; A R Frackelton; R A Nemenoff; J Avruch
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

4.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.

Authors:  C K Chou; T J Dull; D S Russell; R Gherzi; D Lebwohl; A Ullrich; O M Rosen
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

5.  Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity.

Authors:  Y Ebina; E Araki; M Taira; F Shimada; M Mori; C S Craik; K Siddle; S B Pierce; R A Roth; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  Analysis of insulin-receptor phosphorylation sites in intact cells by two-dimensional phosphopeptide mapping.

Authors:  J M Tavaré; R M O'Brien; K Siddle; R M Denton
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

7.  Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin.

Authors:  D O Morgan; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

8.  Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells.

Authors:  H E Tornqvist; J R Gunsalus; R A Nemenoff; A R Frackelton; M W Pierce; J Avruch
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

9.  Relationship of site-specific beta subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase activity.

Authors:  H E Tornqvist; J Avruch
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

10.  Properties of a human insulin receptor with a COOH-terminal truncation. I. Insulin binding, autophosphorylation, and endocytosis.

Authors:  D A McClain; H Maegawa; J Levy; T Huecksteadt; T J Dull; J Lee; A Ullrich; J M Olefsky
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

View more
  13 in total

1.  Approaches to the molecular cloning of protein-tyrosine phosphatases in insulin-sensitive tissues.

Authors:  B J Goldstein; W R Zhang; N Hashimoto; C R Kahn
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

2.  Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system.

Authors:  N Hashimoto; W R Zhang; B J Goldstein
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.

Authors:  R L Khandelwal; S Pugazhenthi
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

4.  In vivo modulation of N-myristoyltransferase activity by orthovanadate.

Authors:  M J King; S Pugazhenthi; R L Khandelwal; R K Sharma
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle.

Authors:  I Chopra; H F Li; H Wang; K A Webster
Journal:  Diabetologia       Date:  2011-12-30       Impact factor: 10.122

6.  Dephosphorylation of autophosphorylated insulin and epidermal-growth-factor receptors by two major subtypes of protein-tyrosine-phosphatase from human placenta.

Authors:  P S Tappia; R P Sharma; G J Sale
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

7.  Dephosphorylation of human insulin-like growth factor I (IGF-I) receptors by membrane-associated tyrosine phosphatases.

Authors:  P Peraldi; S Hauguel-de Mouzon; F Alengrin; E Van Obberghen
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

8.  Effect of streptozotocin-induced diabetes on GLUT-4 phosphorylation in rat adipocytes.

Authors:  N Begum; B Draznin
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

9.  Site-specific dephosphorylation and deactivation of the human insulin receptor tyrosine kinase by particulate and soluble phosphotyrosyl protein phosphatases.

Authors:  M J King; R P Sharma; G J Sale
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

10.  Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells.

Authors:  Nicolas Boute; Samira Boubekeur; Danièle Lacasa; Tarik Issad
Journal:  EMBO Rep       Date:  2003-03       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.